Horizon Kinetics Medical ETF (MEDX)
NASDAQ: MEDX · Real-Time Price · USD
33.19
-0.49 (-1.45%)
Apr 10, 2026, 4:00 PM EDT - Market closed
MEDX Holdings Information
MEDX is an equity ETF with a total of 35 individual holdings. The top holdings are Eli Lilly and Company stock at 16.02%, AbbVie at 8.14%, US BANK MMDA - USBGFS 7 at 7.72%, Novartis AG ADR at 7.43%, and AstraZeneca at 5.87%.
Total Holdings
35
Top 10 Percentage
69.01%
Asset Class
Equity
ETF Category
Health
Assets
18.35M
PE Ratio
22.05
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 16.02% |
| 2 | ABBV | AbbVie Inc. | 8.14% |
| 3 | n/a | US BANK MMDA - USBGFS 7 | 7.72% |
| 4 | NVSN.MX | Novartis AG ADR | 7.43% |
| 5 | LON: AZN | AstraZeneca PLC | 5.87% |
| 6 | JNJ | Johnson & Johnson | 5.79% |
| 7 | BMY | Bristol-Myers Squibb Company | 4.97% |
| 8 | IONS | Ionis Pharmaceuticals, Inc. | 4.76% |
| 9 | AMGN | Amgen Inc. | 4.19% |
| 10 | MRK | Merck & Co., Inc. | 4.11% |
| 11 | ALKS | Alkermes plc | 4.02% |
| 12 | ALNY | Alnylam Pharmaceuticals, Inc. | 3.98% |
| 13 | PFE | Pfizer Inc. | 3.52% |
| 14 | GSK | GSK plc | 3.28% |
| 15 | REGN | Regeneron Pharmaceuticals, Inc. | 2.76% |
| 16 | BIIB | Biogen Inc. | 2.76% |
| 17 | CRSP | CRISPR Therapeutics AG | 2.73% |
| 18 | BEAM | Beam Therapeutics Inc. | 1.26% |
| 19 | NTLA | Intellia Therapeutics, Inc. | 0.99% |
| 20 | VNDA | Vanda Pharmaceuticals Inc. | 0.95% |
| 21 | SDZNY | Sandoz Group AG | 0.79% |
| 22 | HLN | Haleon plc | 0.70% |
| 23 | GALT | Galectin Therapeutics Inc. | 0.65% |
| 24 | EDIT | Editas Medicine, Inc. | 0.46% |
| 25 | REPL | Replimune Group, Inc. | 0.42% |
As of Apr 9, 2026